About PPA   |   Contact Us   |   Sign In   |   Join Now
CE Webinar: A Time of Many: Hepatitis C Solutions in the Interferon-Free Era
Tell a Friend About This EventTell a Friend
CE Webinar: A Time of Many: Hepatitis C Solutions in the Interferon-Free Era

Join us for this convenient online CE webinar!

4/12/2017
When: Wednesday, April 12, 2017
12 to 1 PM
Where: Webinar
Access instructions provided upon registration
United States
Presenter: Jennifer Andres, PharmD, BCPS, Clinical Assistant Professor of Pharmacy Practice, Temple University
Contact: Sara Powers
(717) 234-6151 x. 2


Online registration is closed.
« Go to Upcoming Event List  

A Time of Many: Hepatitis C Solutions in the Interferon-Free Era

originally presented at PPA's 2017 Mid-Year Conference

 

The treatment of Hepatitis C continues to evolve. Interferon-based regimens are "history" and highly effective direct acting antivirals (DAAs) are available for patients. DAAs approved in the last year will be discussed, as well as agents in phase 3 clinical studies. Opportunities for pharmacist involvement in the care of patients with hepatitis C will be highlighted.


Presenters:


Jennifer Andres, PharmD, BCPS, Clinical Assistant Professor of Pharmacy Practice, Temple University School of Pharmacy

Dr. Andres received her PharmD from Temple and completed a PGY1 residency at the Martinsburg Veterans Affairs Medical Center. Following residency, she joined the faculty at PCOM in Atlanta, Georgia while working as a clinical specialist for an internal medicine team at the Atlanta Veterans Affairs Medical Center. She returned to Temple University as a faculty member in 2014. She teaches the therapeutics of hepatitis to third year students, has published several articles on Hepatitis C, and has developed a clinic in this therapeutic area.

   

Target Audience: All pharmacists

  
CE Credit: 1 Contact Hour (0.1 CEUs)

Program Objectives:

At the completion of this activity, the participant will be able to
1. Review epidemiology, pathophysiology, and treatment of Hepatitis C
2. Compare newly FDA-approved treatment options for Hepatitis C
3. Discuss agents that have submitted for FDA review and are in phase 3 clinical trials
  
Schedule: 11:55 AM to 12:00 PM - Attendees log in
12:00 PM to 1:00 PM - CE Program
Activity Type: Application-based
Cost: PPA Members - Free
Non-Members - $30
   *Requests for cancellation refunds must be submitted to PPA at least one day in advance of the webinar. All refunds will be subject to a $5 administrative fee.
UAN: 0159-0000-17-007-L01-P
Requirements to receive credit: Participants must attend the entire program and complete an online evaluation survey within one week. PPA must have your CPE Monitor ID and birthday on file to issue credit.
   


Click here to view current software requirements


The Pennsylvania Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Association Management Software Powered by YourMembership  ::  Legal